People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

Capital Blue Cross has announced that its diabetes-management programs have helped the insurer’s customers lose tens of ...

People with both type 2 diabetes and chronic kidney disease face a heart health double-whammy, a new study says.

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

The cardiovascular outcome benefit of a tighter systolic blood pressure target was affirmed in patients with type 2 diabetes ...

A study of almost 13,000 adults with Type 2 diabetes and high systolic blood pressure assessed if a more intensive treatment ...

Diabetes is very common in people living in post-acute and long-term environments, affecting 25% to 34% of these individuals.

Dietitians often field this question, especially in a diet culture that demonizes sweet stuff as a whole. Here’s what they ...

For patients with diabetes, a systolic target of 120 mm Hg led to a significant reduction in CV events in BPROADS, mirroring ...

Amidst discrepant SPRINT and ACCORD data, this study confirms the benefits seen in nondiabetics, Shawna Nesbitt says.

The Dasman Diabetes Institute has reduced diabetes medications for patients by 50 percent through its Diabetes Overcome ...

A tool powered by artificial intelligence that uses high-speed video to detect changes in blood flow in skin on the face and ...